Cancer Biomarkers Market

Cancer Biomarkers Market (Test Type - PSA Tests, CTC Tests, AFP Tests, CA Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, and KRAS Mutation Tests; Disease Indication - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, and Liver Cancer) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL479
  • Published On : May 2017
  • No. of Pages : 157
  • Category : Healthcare

1. Preface

2. Research Methodology & Assumptions

3. Executive Summary

4. Global Cancer Biomarkers Products Market Overview
     4.1 Introduction (Product Definition)
     4.2 Industry Evolution/Development 
     4.3 Key Market Indicators
     4.4 Market Dynamics
          4.4.1 Drivers
          4.4.2 Restraints
          4.4.3 Opportunity
     4.5  Global Cancer Biomarkers Market Analysis and Forecasts, 2015 – 2025
     4.6 Cancer Biomarkers Market - Global Supply Demand Scenario
     4.7 Porter’s Five Force Analysis
     4.8 Market Outlook
     4.9 Cancer Epidemiology, by region

5. Global Cancer Biomarkers Market Analysis and Forecast by Test Type
     5.1 Key Findings
     5.2 Introduction
     5.3 Market Size (US$ Mn) Forecast, By Test Type
          5.3.1 PSA Tests
          5.3.2 CTC Tests
          5.3.3 AFP Tests
          5.3.4 CA Tests
          5.3.5 HER2 Tests
          5.3.6 BRCA Tests
          5.3.7 ALK Tests
          5.3.8 CEA Tests
          5.3.9 EGFR Mutation Tests
          5.3.10 KRAS Mutation Tests
          5.3.11 Others 
     5.4 Market Attractiveness, By Test Type
     5.5 Key Trends

6. Global Cancer Biomarkers Market Analysis and Forecast by Disease Indication
     6.1 Key Findings
     6.2 Introduction
     6.3 Market Size (US$ Mn) Forecast, By Disease Indication
          6.3.1 Breast Cancer
          6.3.2 Lung Cancer
          6.3.3 Colorectal Cancer
          6.3.4 Melanoma
          6.3.5 Blood Cancer
          6.3.6 Prostate Cancer
          6.3.7 Ovarian Cancer
          6.3.8 Stomach Cancer
          6.3.9 Liver Cancer
          6.3.10 Others
     6.4 Market Attractiveness, By Disease Indication
     6.5 Key Trends

7. Global Cancer Biomarkers Market Analysis and Forecast by Region
     7.1 Key Findings
     7.2 Introduction
          7.2.1 Market Size (US$ Mn) Forecast, By Region
          7.2.2 North America
          7.2.3 Europe
          7.2.4 Asia Pacific
          7.2.5 Latin America
          7.2.6 Middle East and Africa

8. North America Cancer Biomarkers Market Analysis and Forecast by Region
     8.1 Key Findings
     8.2 North America Cancer Biomarkers Market Forecast, by Test Type
     8.3 North America Cancer Biomarkers Market Forecast, by Disease Indication     
     8.4 North America Cancer Biomarkers Market Forecast, by Country
          8.4.1 U.S. Cancer Biomarkers Market Overview
          8.4.2 Canada Cancer Biomarkers Market Overview
     8.5 North America Market Attractiveness Analysis
     8.6 Market Trends

9.  Europe Cancer Biomarkers Market Analysis and Forecast by Region
     9.1 Key Findings
     9.2 Europe Cancer Biomarkers Market Forecast, by Test Type
     9.3 Europe Cancer Biomarkers Market Forecast, by Disease Indication
     9.4 Europe Cancer Biomarkers Market Forecast, by Country
          9.4.1 U.K. Cancer Biomarkers Market Overview
          9.4.2 Germany Cancer Biomarkers Market Overview
          9.4.3 France Cancer Biomarkers Market Overview
          9.4.4 Italy Cancer Biomarkers Market Overview
          9.4.5 Spain Cancer Biomarkers Market Overview
          9.4.6 Russia Cancer Biomarkers Market Overview
          9.4.7 Rest of Europe Cancer Biomarkers Market Overview
     9.5 Europe Market Attractiveness Analysis
     9.6 Market Trends

10.  Asia Pacific Cancer Biomarkers Market Analysis and Forecast by Region
     10.1 Key Findings
     10.2 Asia Pacific Cancer Biomarkers Market Forecast, by Test Type
     10.3 Asia Pacific Cancer Biomarkers Market Forecast, by Disease Indication
     10.4 Asia Pacific Cancer Biomarkers Market Forecast, by Country
          10.4.1 India Cancer Biomarkers Market Overview
          10.4.2 China Cancer Biomarkers Market Overview
          10.4.3 Japan Cancer Biomarkers Market Overview
          10.4.4 Australia & New Zealand Cancer Biomarkers Market Overview
          10.4.5 Rest of APAC Cancer Biomarkers Market Overview
     10.5 Asia Pacific Market Attractiveness Analysis
     10.6 Market Trends

11. Latin America Cancer Biomarkers Market Analysis and Forecast by Region
     11.1 Key Findings
     11.2 Latin America Cancer Biomarkers Market Forecast, by Test Type
     11.3 Latin America Cancer Biomarkers Market Forecast, by Disease Indication
     11.4 Latin America Cancer Biomarkers Market Forecast, by Country
          11.4.1 Brazil Cancer Biomarkers Market Overview
          11.4.2 Mexico Cancer Biomarkers Market Overview
          11.4.3 Rest of LATAM Cancer Biomarkers Market Overview
     11.5 Latin America Market Attractiveness Analysis
     11.6 Market Trends

12. Middle East and Africa Cancer Biomarkers Market Analysis and Forecast by Region
     12.1 Key Findings
     12.2 Middle East and Africa Cancer Biomarkers Market Forecast, by Test Type
     12.3 Middle East and Africa Cancer Biomarkers Market Forecast, by Disease Indication
     12.4 Middle East and Africa Cancer Biomarkers Market Forecast, by Country
          12.4.1 South Africa Cancer Biomarkers Market Overview
          12.4.2 GCC countries Cancer Biomarkers Market Overview
          12.4.3 Rest of MEA Cancer Biomarkers Market Overview
     12.5 Middle East and Africa Market Attractiveness Analysis
     12.6 Market Trends

13.  Competitive Landscape
     13.1 Market Share Analysis, by Company
     13.2 Competition Matrix
     13.3 Company Profiles
          13.3.1 Abbott Laboratories
                   13.3.1.1 Company Details
                   13.3.1.2 Business Overview
                   13.3.1.3 Financial Overview
                   13.3.1.4 Strategic Overview
                   13.3.1.5 SWOT Analysis
          13.3.2 Merck & Co., Inc.
                   13.3.2.1 Company Details
                   13.3.2.2 Business Overview
                   13.3.2.3 Financial Overview
                   13.3.2.4 Strategic Overview
                   13.3.2.5 SWOT Analysis
          13.3.3 Thermo Fisher Scientific Inc
                   13.3.3.1 Company Details
                   13.3.3.2 Business Overview
                   13.3.3.3 Financial Overview
                   13.3.3.4 Strategic Overview
                   13.3.3.5 SWOT Analysis
          13.3.4 Illumina, Inc.
                   13.3.4.1 Company Details
                   13.3.4.2 Business Overview
                   13.3.4.3 Financial Overview
                   13.3.4.4 Strategic Overview
                   13.3.4.5 SWOT Analysis
          13.3.5 bioMérieux SA
                   13.3.5.1 Company Details
                   13.3.5.2 Business Overview
                   13.3.5.3 Financial Overview
                   13.3.5.4 Strategic Overview
                   13.3.5.5 SWOT Analysis
          13.3.6 QIAGEN
                   13.3.6.1 Company Details
                   13.3.6.2 Business Overview
                   13.3.6.3 Financial Overview
                   13.3.6.4 Strategic Overview
                   13.3.6.5 SWOT Analysis
          13.3.7 Agilent Technologies, Inc.
                   13.3.7.1 Company Details
                   13.3.7.2 Business Overview
                   13.3.7.3 Financial Overview
                   13.3.7.4 Strategic Overview
                   13.3.7.5 SWOT Analysis
          13.3.8 Hologic, Inc.
                   13.3.8.1 Company Details
                   13.3.8.2 Business Overview
                   13.3.8.3 Financial Overview
                   13.3.8.4 Strategic Overview
                   13.3.8.5 SWOT Analysis
          13.3.9 Novartis AG
                   13.3.9.1 Company Details
                   13.3.9.2 Business Overview
                   13.3.9.3 Financial Overview
                   13.3.9.4 Strategic Overview
                   13.3.9.5 SWOT Analysis
          13.3.10 F. Hoffmann-La Roche Ltd.
                   13.3.10.1 Company Details
                   13.3.10.2 Business Overview
                   13.3.10.3 Financial Overview
                   13.3.10.4 Strategic Overview
                   13.3.10.5 SWOT Analysis
          13.3.11 Genomic Health, Inc.
                   13.3.11.1 Company Details
                   13.3.11.2 Business Overview
                   13.3.11.3 Financial Overview
                   13.3.11.4 Strategic Overview
                   13.3.11.5 SWOT Analysis

List of Table

Table 01: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015–2025
Table 02: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015–2025
Table 03: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, By Region Type, 2015 – 2025
Table 04: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015–2025
Table 05: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015–2025
Table 06: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015–2025
Table 07: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015–2025
Table 08: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015–2025
Table 09: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015–2025
Table 10: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015–2025
Table 11: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015–2025
Table 12: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015–2025
Table 13: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015–2025
Table 14: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015–2025
Table 15: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015–2025
Table 16: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Test Type, 2015–2025
Table 17: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Disease Indication, 2015–2025
Table 18: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, By Country, 2015–2025

List of Figures

Figure 01: Global Cancer Biomarkers Market Size (US$ Mn) Forecast, 2016 – 2025
Figure 02: Global Cancer Biomarkers Market Value Share Analysis By Test Type, 2017 and 2025
Figure 03: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by PSA Tests, 2016-2025
Figure 04: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CTC Tests, 2016-2025
Figure 05: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by AFP Tests, 2016-2025
Figure 06: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CA Tests, 2016-2025
Figure 07: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by HER2 Tests, 2016-2025
Figure 08: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by BRCA Tests, 2016-2025
Figure 09: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ALK Tests, 2016-2025
Figure 10: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CEA Tests, 2016-2025
Figure 11: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by EGFR Tests, 2016-2025
Figure 12: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by KRAS Mutation Tests, 2016-2025
Figure 13: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016-2025
Figure 14: Cancer Biomarkers Market Attractiveness Analysis By Test Type
Figure 15: Global Cancer Biomarkers Market Value Share Analysis By Disease Indication, 2017 and 2025
Figure 16: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2016-2025
Figure 17: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2016-2025
Figure 18: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2016-2025
Figure 19: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melanoma, 2016-2025
Figure 20: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood Cancer, 2016-2025
Figure 21: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prostate Cancer, 2016-2025
Figure 22: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ovarian Cancer, 2016-2025
Figure 23: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stomach Cancer, 2016-2025
Figure 24: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liver Cancer, 2016-2025
Figure 25: Global Cancer Biomarkers Test Types Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016-2025
Figure 26: Cancer Biomarkers Market Attractiveness Analysis By Disease Indication
Figure 27: Global Cancer Biomarkers Market Value Share Analysis By Region Type, 2017 and 2025
Figure 28: Cancer Biomarkers Market Attractiveness Analysis, By Region Type
Figure 29: North America Cancer Biomarkers Market Size (US$ Mn) Forecast, 2017 – 2025
Figure 30: North America Market Attractiveness Analysis By Country
Figure 31: North America Cancer Biomarkers Market Value Share Analysis By Test Type, 2017 and 2025
Figure 32: North America Cancer Biomarkers Market Value Share Analysis By Disease Indication, 2017 and 2025
Figure 33: North America Market Value Share Analysis By Country, 2017 and 2025
Figure 34: North America Market Attractiveness Analysis, By Test Type
Figure 35: North America Market Attractiveness Analysis, By Disease Indication
Figure 36: Europe Cancer Biomarkers Market Size (US$ Mn) Forecast, 2016 – 2025
Figure 37: Europe Market Attractiveness Analysis By Country
Figure 38: Europe Cancer Biomarkers Market Value Share Analysis By Test Type, 2017 and 2025
Figure 39: Europe Cancer Biomarkers Market Value Share Analysis By Disease Indication, 2017 and 2025
Figure 40: Europe Market Value Share Analysis By Country, 2017 and 2025
Figure 41: Europe Market Attractiveness Analysis, By Test Type
Figure 42: Europe Market Attractiveness Analysis, By Disease Indication
Figure 43: Asia Pacific Cancer Biomarkers Market Size (US$ Mn) Forecast, 2016 – 2025
Figure 44: Asia Pacific Market Attractiveness Analysis By Country
Figure 45: Asia Pacific Cancer Biomarkers Market Value Share Analysis By Test Type, 2017 and 2025
Figure 46: Asia Pacific Cancer Biomarkers Market Value Share Analysis By Disease Indication, 2017 and 2025
Figure 47: Europe Market Value Share Analysis By Country, 2017 and 2025
Figure 48: Asia Pacific Market Attractiveness Analysis, By Test Type
Figure 49: Asia Pacific Market Attractiveness Analysis, By Disease Indication
Figure 50: Latin America Cancer Biomarkers Market Size (US$ Mn) Forecast, 2016 – 2025
Figure 51: Latin America Market Attractiveness Analysis By Country
Figure 52: Latin America Cancer Biomarkers Market Value Share Analysis By Test Type, 2017 and 2025
Figure 53: Latin America Cancer Biomarkers Market Value Share Analysis By Disease Indication, 2017 and 2025
Figure 54: Latin America Market Value Share Analysis By Country, 2017 and 2025
Figure 55: Latin America Market Attractiveness Analysis, By Test Type
Figure 56: Latin America Market Attractiveness Analysis, By Disease Indication
Figure 57: Middle East & Africa Cancer Biomarkers Market Size (US$ Mn) Forecast, 2016 – 2025
Figure 58: Middle East & Africa Market Attractiveness Analysis By Country
Figure 59: Middle East & Africa Cancer Biomarkers Market Value Share Analysis By Test Type, 2017 and 2025
Figure 60: Middle East & Africa Cancer Biomarkers Market Value Share Analysis By Disease Indication, 2017 and 2025
Figure 61: Middle East & Africa Market Value Share Analysis By Country, 2017 and 2025
Figure 62: Middle East & Africa Market Attractiveness Analysis, By Test Type
Figure 63: Middle East & Africa Market Attractiveness Analysis, By Disease Indication
Figure 64: Global Cancer Biomarkers Market Share Analysis By Company (2015)